Atlas Trials

Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

Clinical trial NCT05711823 · UNKNOWN

Trial details

NCT number
NCT05711823
Sponsor
Guangxi Medical University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2024-07-01
Primary completion
2024-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.